Clinical trials of BioNTech’s cancer vaccines are due to begin in the UK this year, marking a major step towards their eventual sale on the open market, Ugur Sahin, a top executive at the German company, told Der Spiegel magazine.
Spain asks “fire tourists” to stay away from forest fire
March 28, 2023
